東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The effectiveness of chemoradiation ...

Sinclair, Suzanne Marie.

FindBook

Google Book

Amazon

博客來

The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center./
作者:	Sinclair, Suzanne Marie.
面頁冊數:	137 p.
附註:	Adviser: Patti Groome.
Contained By:	Masters Abstracts International42-01.
標題:	Health Sciences, Oncology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ81122
ISBN:	9780612811225

The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center.
Sinclair, Suzanne Marie.

The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center. - 137 p.

Adviser: Patti Groome.

Thesis (M.Sc.)--Queen's University (Canada), 2003.

Design. The current study is a observational retrospective cohort design involving the use of historical controls at KRCC. All data collection was retrospective. (Abstract shortened by UMI.)

ISBN: 9780612811225Subjects--Topical Terms:

1018566
Health Sciences, Oncology.

The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center.
LDR:01951nam 2200301 a 45 001 958530
005 20110704
008 110704s2003 eng d
020 $a 9780612811225
035 $a (UMI)AAIMQ81122
035 $a AAIMQ81122
040 $a UMI $c UMI
100 1 $a Sinclair, Suzanne Marie. $3 1281990
245 1 4 $a The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center.
300 $a 137 p.
500 $a Adviser: Patti Groome.
500 $a Source: Masters Abstracts International, Volume: 42-01, page: 0217.
502 $a Thesis (M.Sc.)--Queen's University (Canada), 2003.
520 $a Design. The current study is a observational retrospective cohort design involving the use of historical controls at KRCC. All data collection was retrospective. (Abstract shortened by UMI.)
520 $a Background. Patients with Stage III non-small cell lung cancer represent a major problem in terms of selection of optimal treatment, as traditional treatment options consisting of radiation or surgery, have not had a major impact on survival of these patients (23, 26). However, within the last few years' evidence from clinical trials has demonstrated a survival benefit from combined modality therapy (CMT---chemotherapy, combined with high-dose radiotherapy), for Stage III NSCLC patients (27, 63, 69).
520 $a Purpose. The proposed study is part of the clinical audit pathway that examines the effectiveness of CMT treatment now offered to Stage III NSCLC patients at KRCC. Survival outcomes of the KRCC treatment policy change are measured by patients' median and long-term survival, with a comparison to historical controls.
590 $a School code: 0283.
650 4 $a Health Sciences, Oncology. $3 1018566
650 4 $a Health Sciences, Radiology. $3 1019076
690 $a 0574
690 $a 0992
710 2 0 $a Queen's University (Canada). $3 1017786
773 0 $t Masters Abstracts International $g 42-01.
790 $a 0283
790 1 0 $a Groome, Patti, $e advisor
791 $a M.Sc.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ81122